Health Secretary Robert Kennedy Jr. ended the COVID emergency use rules. This decision prompts a review of the original evidence for the Pfizer vaccine. The key question is whether its benefits truly outweighed the risks when first approved.
Health Secretary Robert F. Kennedy Jr. recently ended the emergency use authorizations for COVID-19 vaccines. This action invites a careful review of the evidence used to approve the first shots. The focus now falls on the early decisions made by the FDA regarding the Pfizer BioNTech vaccine.
The FDA granted the first emergency use based on its view that known benefits outweighed potential risks. At the time officials highlighted the urgent need to fight the pandemic. Yet new questions arise about how complete the safety data was during those initial months.
Today experts call for a full balance of all available information. They seek to understand the true impact on public health. This process aims to guide better decisions for future health policies and vaccine programs.
Original Author: Yaakov Ophir | Source: Brownstone Institute
91.485 SRY